Skip to main navigation
VivoSim Labs, Inc. homepage
  • Technology
    • NAMkind™ Intestine Model
    • NAMkind™ Liver Model
  • Services
    • Gastrointestinal Toxicology Services
    • Investigative Toxicology Services
    • Liver Toxicology Services
  • Company
    • About
    • Leadership
    • Board of Directors
  • Investors
    • Overview
    • Stock Quote & Chart
      • Historical Stock Quote
      • Investment Calculator
    • Press Releases
    • SEC Filings
    • Corporate Governance
      • Documents & Charters
      • Leadership Team
      • Board of Directors
      • Committee Composition
    • Investor Alerts
    • Investor Contacts
    • Investor Presentations
  • Contact

SEC Filing Details

  • Technology
    • NAMkind™ Intestine Model
    • NAMkind™ Liver Model
  • Services
    • Gastrointestinal Toxicology Services
    • Investigative Toxicology Services
    • Liver Toxicology Services
  • Company
    • About
    • Leadership
    • Board of Directors
  • Investors
    • Overview
    • Stock Quote & Chart
      • Historical Stock Quote
      • Investment Calculator
    • Press Releases
    • SEC Filings
    • Corporate Governance
      • Documents & Charters
      • Leadership Team
      • Board of Directors
      • Committee Composition
    • Investor Alerts
    • Investor Contacts
    • Investor Presentations
  • Contact

Document Details

Form
SCHEDULE 13G
Filing Date
Apr 6, 2026
Document Date
Apr 6, 2026
Form Description
SCHEDULE 13G - Description
Filing Group
Other
Company
VivoSim Labs, Inc.
Issuer
VIVOSIM LABS, INC.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

© VivoSim Labs, Inc. 2026 | Contact Us

VivoSim Labs, Inc. homepage
  • Technology
    • NAMkind™ Intestine Model
    • NAMkind™ Liver Model
  • Services
    • Gastrointestinal Toxicology Services
    • Investigative Toxicology Services
    • Liver Toxicology Services
  • Company
    • About
    • Leadership
    • Board of Directors
  • Investors
    • Overview
    • Stock Quote & Chart
      • Historical Stock Quote
      • Investment Calculator
    • Press Releases
    • SEC Filings
    • Corporate Governance
      • Documents & Charters
      • Leadership Team
      • Board of Directors
      • Committee Composition
    • Investor Alerts
    • Investor Contacts
    • Investor Presentations
  • Contact